Search Results - PUJADE-LAURAINE, ERIC

Refine Results
  1. 1
    Bevacizumab and oral metronomic cyclophosphamide in platinum-resistant ovarian cancer

    Bevacizumab and oral metronomic cyclophosphamide in platinum-resistant ovarian cancer by Pujade-Lauraine, Eric

    Published 2013
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  2. 2
    Olaparib as maintenance treatment for patients with platinum-sensitive relapsed ovarian cancer

    Olaparib as maintenance treatment for patients with platinum-sensitive relapsed ovarian cancer by Ledermann, Jonathan A., Pujade-Lauraine, Eric

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  3. 3
    High Expression of HLA-G in Ovarian Carcinomatosis: The Role of Interleukin-1β

    High Expression of HLA-G in Ovarian Carcinomatosis: The Role of Interleukin-1β by Ullah, Matti, Azazzen, Dallel, Kaci, Rachid, Benabbou, Nadia, Pujade Lauraine, Eric, Pocard, Marc, Mirshahi, Massoud

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  4. 4
    HER2 Status in Ovarian Carcinomas: A Multicenter GINECO Study of 320 Patients

    HER2 Status in Ovarian Carcinomas: A Multicenter GINECO Study of 320 Patients by Tuefferd, Marianne, Couturier, Jérôme, Penault-Llorca, Frédérique, Vincent-Salomon, Anne, Broët, Philippe, Guastalla, Jean-Paul, Allouache, Djelila, Combe, Martin, Weber, Béatrice, Pujade-Lauraine, Eric, Camilleri-Broët, Sophie

    Published 2007
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  5. 5
    Plasma endothelial protein C receptor influences innate immune response in ovarian cancer by decreasing the population of natural killer and TH17 helper cells

    Plasma endothelial protein C receptor influences innate immune response in ovarian cancer by decreasing the population of natural killer and TH17 helper cells by AZZAZENE, DALEL, THAWADI, HAMDA AL, FARSI, HALEMA AL, BESBES, SAMAHER, GEYL, CAROLINE, MIRSHAHI, SHAHSOLTAN, PARDO, JULIA, FAUSSAT, ANNE MARIE, JEANNETTE, SORIA, THERWATH, AMU, PUJADE-LAURAINE, ERIC, MIRSHAHI, MASSOUD

    Published 201
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  6. 6
    Predicting tumor response and outcome of second-look surgery with (18)F-FDG PET/CT: insights from the GINECO CHIVA phase II trial of neoadjuvant chemotherapy plus nintedanib in stage IIIc-IV FIGO ovarian cancer

    Predicting tumor response and outcome of second-look surgery with (18)F-FDG PET/CT: insights from the GINECO CHIVA phase II trial of neoadjuvant chemotherapy plus nintedanib in sta... by Aide, Nicolas, Fauchille, Pauline, Coquan, Elodie, Ferron, Gwenael, Combe, Pierre, Meunier, Jérome, Alexandre, Jerôme, Berton, Dominique, Leary, Alexandra, De Rauglaudre, Gaétan, Bonichon, Nathalie, Pujade Lauraine, Eric, Joly, Florence

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  7. 7
    Endothelial protein C receptor expressed by ovarian cancer cells as a possible biomarker of cancer onset

    Endothelial protein C receptor expressed by ovarian cancer cells as a possible biomarker of cancer onset by DUCROS, ELODIE, MIRSHAHI, SHAHSOLTAN, AZZAZENE, DALEL, CAMILLERI-BROËT, SOPHIE, MERY, ELIANE, FARSI, HALEMA AL, ALTHAWADI, HAMDA, BESBESS, SAMAHER, CHIDIAC, JEAN, PUJADE-LAURAINE, ERIC, THERWATH, AMU, SORIA, JEANNETTE, MIRSHAHI, MASSOUD

    Published 2012
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  8. 8
    Systematic analysis of circulating soluble angiogenesis-associated proteins in ICON7 identifies Tie2 as a biomarker of vascular progression on bevacizumab

    Systematic analysis of circulating soluble angiogenesis-associated proteins in ICON7 identifies Tie2 as a biomarker of vascular progression on bevacizumab by Zhou, Cong, Clamp, Andrew, Backen, Alison, Berzuini, Carlo, Renehan, Andrew, Banks, Rosamonde E, Kaplan, Richard, Scherer, Stefan J, Kristensen, Gunnar B, Pujade-Lauraine, Eric, Dive, Caroline, Jayson, Gordon C

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  9. 9
    CXCL12 expression by healthy and malignant ovarian epithelial cells

    CXCL12 expression by healthy and malignant ovarian epithelial cells by Machelon, Véronique, Gaudin, Françoise, Camilleri-Broët, Sophie, Nasreddine, Salam, Bouchet-Delbos, Laurence, Pujade-Lauraine, Eric, Alexandre, Jerôme, Gladieff, Laurence, Arenzana-Seisdedos, Fernando, Emilie, Dominique, Prévot, Sophie, Broët, Philippe, Balabanian, Karl

    Published 2011
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  10. 10
    Part I of GANNET53: A European Multicenter Phase I/II Trial of the Hsp90 Inhibitor Ganetespib Combined With Weekly Paclitaxel in Women With High-Grade, Platinum-Resistant Epithelial Ovarian Cancer—A Study of the GANNET53 Consortium

    Part I of GANNET53: A European Multicenter Phase I/II Trial of the Hsp90 Inhibitor Ganetespib Combined With Weekly Paclitaxel in Women With High-Grade, Platinum-Resistant Epithelia... by Ray-Coquard, Isabelle, Braicu, Ioana, Berger, Regina, Mahner, Sven, Sehouli, Jalid, Pujade-Lauraine, Eric, Cassier, Philippe Alexandre, Moll, Ute Martha, Ulmer, Hanno, Leunen, Karin, Zeimet, Alain Gustave, Marth, Christian, Vergote, Ignace, Concin, Nicole

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  11. 11
    Patient-Reported Outcome Results From the Open-Label Phase III AURELIA Trial Evaluating Bevacizumab-Containing Therapy for Platinum-Resistant Ovarian Cancer

    Patient-Reported Outcome Results From the Open-Label Phase III AURELIA Trial Evaluating Bevacizumab-Containing Therapy for Platinum-Resistant Ovarian Cancer by Stockler, Martin R., Hilpert, Felix, Friedlander, Michael, King, Madeleine T., Wenzel, Lari, Lee, Chee Khoon, Joly, Florence, de Gregorio, Nikolaus, Arranz, José Angel, Mirza, Mansoor Raza, Sorio, Roberto, Freudensprung, Ulrich, Sneller, Vesna, Hales, Gill, Pujade-Lauraine, Eric

    Published 2014
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  12. 12
    Surgical Implications of Advanced Low-Grade Serous Ovarian Cancer: Analysis of the Database of the Tumeurs Malignes Rares Gynécologiques Network

    Surgical Implications of Advanced Low-Grade Serous Ovarian Cancer: Analysis of the Database of the Tumeurs Malignes Rares Gynécologiques Network by Bonsang-Kitzis, Hélène, Panchbhaya, Nabilah, Bats, Anne-Sophie, Pujade-Lauraine, Eric, Pautier, Patricia, Ngô, Charlotte, Le Frère-Belda, Marie-Aude, Kalbacher, Elsa, Floquet, Anne, Berton-Rigaud, Dominique, Lefeuvre-Plesse, Claudia, Fabbro, Michel, Ray-Coquard, Isabelle, Lécuru, Fabrice

    Published 2022
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  13. 13
    Olaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed, advanced ovarian cancer: Japan subset from the PAOLA-1/ENGOT-ov25 trial

    Olaparib plus bevacizumab as maintenance therapy in patients with newly diagnosed, advanced ovarian cancer: Japan subset from the PAOLA-1/ENGOT-ov25 trial by Fujiwara, Keiichi, Fujiwara, Hiroyuki, Yoshida, Hiroyuki, Satoh, Toyomi, Yonemori, Kan, Nagao, Shoji, Matsumoto, Takashi, Kobayashi, Hiroaki, Bourgeois, Hughes, Harter, Philipp, Mosconi, Anna Maria, Vazquez, Isabel Palacio, Reinthaller, Alexander, Fujita, Tomoko, Rowe, Philip, Pujade-Lauraine, Eric, Ray-Coquard, Isabelle

    Published 2021
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  14. 14
    Exploratory outcome analyses according to stage and/or residual disease in the ICON7 trial of carboplatin and paclitaxel with or without bevacizumab for newly diagnosed ovarian cancer

    Exploratory outcome analyses according to stage and/or residual disease in the ICON7 trial of carboplatin and paclitaxel with or without bevacizumab for newly diagnosed ovarian can... by González Martín, Antonio, Oza, Amit M., Embleton, Andrew C., Pfisterer, Jacobus, Ledermann, Jonathan A., Pujade-Lauraine, Eric, Kristensen, Gunnar, Bertrand, Monique A., Beale, Philip, Cervantes, Andrés, Kent, Emma, Kaplan, Richard S., Parmar, Mahesh K.B., Scotto, Nana, Perren, Timothy J.

    Published 2019
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  15. 15
    Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 randomised trial

    Standard chemotherapy with or without bevacizumab in advanced ovarian cancer: quality-of-life outcomes from the International Collaboration on Ovarian Neoplasms (ICON7) phase 3 ran... by Stark, Dan, Nankivell, Matthew, Pujade-Lauraine, Eric, Kristensen, Gunnar, Elit, Lorraine, Stockler, Martin, Hilpert, Felix, Cervantes, Andrés, Brown, Julia, Lanceley, Anne, Velikova, Galina, Sabate, Eduardo, Pfisterer, Jacobus, Carey, Mark S, Beale, Philip, Qian, Wendi, Swart, Ann Marie, Oza, Amit, Perren, Tim

    Published 2013
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  16. 16
    Oncologic Trogocytosis of an Original Stromal Cells Induces Chemoresistance of Ovarian Tumours

    Oncologic Trogocytosis of an Original Stromal Cells Induces Chemoresistance of Ovarian Tumours by Rafii, Arash, Mirshahi, Pejman, Poupot, Mary, Faussat, Anne-Marie, Simon, Anne, Ducros, Elodie, Mery, Eliane, Couderc, Bettina, Lis, Raphael, Capdet, Jerome, Bergalet, Julie, Querleu, Denis, Dagonnet, Francoise, Fournié, Jean-Jacques, Marie, Jean-Pierre, Pujade-Lauraine, Eric, Favre, Gilles, Soria, Jeanine, Mirshahi, Massoud

    Published 2008
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  17. 17
    Update on rare epithelial ovarian cancers: based on the Rare Ovarian Tumors Young Investigator Conference

    Update on rare epithelial ovarian cancers: based on the Rare Ovarian Tumors Young Investigator Conference by Jang, Ji Yon Agnes, Yanaihara, Nozomu, Pujade-Lauraine, Eric, Mikami, Yoshiki, Oda, Katsutoshi, Bookman, Michael, Ledermann, Jonathan, Shimada, Muneaki, Kiyokawa, Takako, Kim, Byoung-Gie, Matsumura, Noriomi, Kaku, Tsunehisa, Kuroda, Takafumi, Nagayoshi, Yoko, Kawabata, Ayako, Iida, Yasushi, Kim, Jae-Weon, Quinn, Michael, Okamoto, Aikou

    Published 2017
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  18. 18
    Safety of bevacizumab in clinical practice for recurrent ovarian cancer: A retrospective cohort study

    Safety of bevacizumab in clinical practice for recurrent ovarian cancer: A retrospective cohort study by SELLE, FRÉDÉRIC, EMILE, GEORGE, PAUTIER, PATRICIA, ASMANE, IRÈNE, SOARES, DANIELE G., KHALIL, AHMED, ALEXANDRE, JEROME, LHOMMÉ, CATHERINE, RAY-COQUARD, ISABELLE, LOTZ, JEAN-PIERRE, GOLDWASSER, FRANÇOIS, TAZI, YOUSSEF, HEUDEL, PIERRE, PUJADE-LAURAINE, ERIC, GOUY, SÉBASTIEN, TREDAN, OLIVIER, BARBAZA, MARIE O., ADY-VAGO, NORA, DUBOT, CORALINE

    Published 2016
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  19. 19
    Concordance Between Tumor and Germline BRCA Status in High-Grade Ovarian Carcinoma Patients in the Phase III PAOLA-1/ENGOT-ov25 Trial

    Concordance Between Tumor and Germline BRCA Status in High-Grade Ovarian Carcinoma Patients in the Phase III PAOLA-1/ENGOT-ov25 Trial by Callens, Céline, Vaur, Dominique, Soubeyran, Isabelle, Rouleau, Etienne, Just, Pierre-Alexandre, Guillerm, Erell, Golmard, Lisa, Goardon, Nicolas, Sevenet, Nicolas, Cabaret, Odile, Harter, Philipp, Gonzalez-Martin, Antonio, Fujiwara, Keiichi, Cecere, Sabrina Chiara, Colombo, Nicoletta, Marth, Christian, Vergote, Ignace, Maenpaa, Johanna, Pujade-Lauraine, Eric, Ray-Coquard, Isabelle

    Published 2020
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:
  20. 20
    Health-related quality of life and patient-centred outcomes with olaparib maintenance after chemotherapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2 mutation (SOLO2/ENGOT Ov-21): a placebo-controlled, phase 3 randomised trial

    Health-related quality of life and patient-centred outcomes with olaparib maintenance after chemotherapy in patients with platinum-sensitive, relapsed ovarian cancer and a BRCA1/2... by Friedlander, Michael, Gebski, Val, Gibbs, Emma, Davies, Lucy, Bloomfield, Ralph, Hilpert, Felix, Wenzel, Lari B, Eek, Daniel, Rodrigues, Manuel, Clamp, Andrew, Penson, Richard T, Provencher, Diane, Korach, Jacob, Huzarski, Tomasz, Vidal, Laura, Salutari, Vanda, Scott, Clare, Nicoletto, Maria Ornella, Tamura, Kenji, Espinoza, David, Joly, Florence, Pujade-Lauraine, Eric

    Published 2018
    Get full text Get full text Get full text
    Text
    Save to List
    Saved in:

Search Tools: